These lines of evidence support our observation of a positive correlation between CCL2 and CD4+ T cells, macrophages, neutrophils, myeloid dendritic cells and NK cells infiltrating GBM, suggesting that CCL2 may remodel the TIME of GBM. The gene discussed is CD4; the disease is glioblastoma.